-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Dutch biotech startup Lava Therapeutics listed on the Nasdaq with an initial public offering (IPO) of US$100.
Emerging γδ T cell therapy
Emerging γδ T cell therapyImmune T cells are the main targets of cancer immunotherapy.
bioon.
Lava Therapeutics, leader in γδ T cell therapy
Lava Therapeutics, leader in γδ T cell therapyLava, which focuses on transforming the expertise of the bispecific γδ T cell adaptor into cancer therapy, was established in 2016.
bioon.
bioon.
bioon.
bioon.
Xiaobian recommendedConference2021 (12th) Cell Therapy Online International Symposium
meetinghttp://meeting.
http://meeting.